Holen Sie sich die Stockscreener-App
23.24
0.43%
-0.1222
Schlusskurs vom Vortag:
$23.36
Offen:
$23.1
24-Stunden-Volumen:
1.44M
Relative Volume:
0.29
Marktkapitalisierung:
$11.56B
Einnahmen:
$4.72B
Nettoeinkommen (Verlust:
$-232.00M
KGV:
-49.83
EPS:
-0.4663
Netto-Cashflow:
$284.00M
1W Leistung:
-10.85%
1M Leistung:
-6.32%
6M Leistung:
+23.99%
1J Leistung:
+108.80%
1-Tages-Spanne:
$22.79
$23.36
1-Wochen-Bereich:
$22.79
$25.48
52-Wochen-Spanne:
$8.02
$27.72
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
23.26 | 11.61B | 4.72B | -232.00M | 284.00M | -0.4663 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.93 | 56.49B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
119.79 | 51.26B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.18 | 45.79B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.77 | 36.16B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
513.47 | 20.96B | 3.13B | 1.27B | 1.12B | 26.39 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Hochstufung | Argus | Hold → Buy |
| 2025-10-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Barclays Reaffirms Their Buy Rating on Elanco Animal Health (ELAN) - The Globe and Mail
A Look At Elanco Animal Health’s Valuation After A Year Of Strong Returns And Recent Share Price Pullback - Yahoo Finance
How Elanco Animal Health Incorporated stock performs in high volatility marketsJuly 2025 Price Swings & Real-Time Market Sentiment Alerts - Naître et grandir
Teachers Retirement System of The State of Kentucky Purchases Shares of 110,000 Elanco Animal Health Incorporated $ELAN - MarketBeat
Stifel reiterates Buy rating on Elanco Animal Health stock By Investing.com - Investing.com Australia
Injected Veterinary Pain Management Drugs Market Set to Witness - openPR.com
Picton Mahoney Asset Management Invests $7.49 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
Dimensional Fund Advisors LP Has $497.61 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Sold by Black Creek Investment Management Inc. - MarketBeat
Elanco (ELAN) EVP awarded stock, options and disposes shares for taxes - Stock Titan
Elanco (NYSE: ELAN) CEO receives large stock grants and tax share sale - Stock Titan
Elanco (ELAN) CAO reports RSU grants and tax-withholding share disposal - Stock Titan
Elanco (ELAN) executive logs new stock grants and tax withholding share disposal - Stock Titan
Elanco (ELAN) CFO VanHimbergen receives new stock and option grants - Stock Titan
Elanco (ELAN) executive equity awards and tax share withholding detailed - Stock Titan
ELAN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Royce & Associates LP Buys 105,632 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Agriculture Biotechnology Industry Research and Global Forecast Report 2025-2030, Profiles of Prominent PlayersBayer, Corteva Agriscience, BASF, Syngenta, Zoetis, Elanco Animal Health, Novonesis - GlobeNewswire
Elanco at TD Cowen Conference: Strategic Growth and Industry Outlook - Investing.com
Elanco Animal Health (ELAN) Stock Analysis: Navigating a 8.97% Potential Upside in the Booming Animal Health Market - DirectorsTalk Interviews
Elanco Animal Health Incorporated (NYSE:ELAN) Short Interest Update - MarketBeat
TD Asset Management Inc Has $21.87 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (ELAN) Is Up 5.7% After Beating Q4 Views And Raising 2026 Innovation Outlook - simplywall.st
JPMorgan Chase & Co. Buys 1,394,839 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Q4 2025 Earnings Highlights - Intellectia AI
PetMed, Elanco, Tractor Supply Settle Flea & Tick Med Claims - Law360
Elanco (ELAN) Q4 2025 Earnings Call Transcript - AOL.com
Chewy reaches settlement in Elanco flea and tick antitrust litigation - DVM360
Elanco Animal Health Q4 Loss Deepens And Tests Bullish Profitability Narratives - simplywall.st
Amlan International and Elanco Collaborate on Japanese Educational Seminars Focused on Calf Health - Yahoo Finance
Jim Cramer Highlights Elanco’s “Comeback Story” - Yahoo Finance
Primecap Management Co. CA Has $1.01 Billion Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco’s AHV Deal And Befrena Win Reshape Growth And Valuation Story - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Henry Schein (HSIC) - The Globe and Mail
Morgan Stanley Raises Price Target for Elanco Animal Health (ELA - GuruFocus
Elanco Animal Health (NYSE:ELAN) Given New $24.00 Price Target at Morgan Stanley - MarketBeat
Keybanc Raises Price Target for ELAN, Maintains Overweight Ratin - GuruFocus
Elanco Animal Health (NYSE:ELAN) Given New $29.00 Price Target at KeyCorp - MarketBeat
KeyBanc raises Elanco Animal Health price target on product strength By Investing.com - Investing.com Canada
Elanco Animal Health Incorporated (NYSE:ELAN) Q4 2025 Earnings Call Transcript - Insider Monkey
Ameritas Investment Partners Inc. Invests $1.88 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco (ELAN) Surpasses Revenue Expectations and Forecasts Growt - GuruFocus
Decoding Elanco Animal Health Inc (ELAN): A Strategic SWOT Insig - GuruFocus
Elanco (ELAN) Focuses on Growth through Innovation and Cash Flow Management - GuruFocus
Elanco (ELAN) officer granted 56.63 deferred stock units in Form 4 - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons awarded new deferred stock units - Stock Titan
Elanco (NYSE: ELAN) CFO receives new deferred stock unit grant - Stock Titan
Elanco Animal Health Q4 Earnings Call Highlights - MarketBeat
Elanco Animal Health Inc (ELAN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus - Investing.com Canada
Elanco Animal Health (ELAN) Receives Outperform Rating with Rais - GuruFocus
Elanco Animal Health (NYSE:ELAN) Price Target Raised to $30.00 at Leerink Partners - MarketBeat
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.05%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):